RIALOND Trademark

Trademark Overview


On Thursday, November 10, 2016, a trademark application was filed for RIALOND with the United States Patent and Trademark Office. The USPTO has given the RIALOND trademark a serial number of 87232883. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 29, 2024. This trademark is owned by Novartis AG. The RIALOND trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the preven...
rialond

General Information


Serial Number87232883
Word MarkRIALOND
Filing DateThursday, November 10, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 29, 2024
Registration Number5289265
Registration DateTuesday, September 19, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2017

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 29, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH

Trademark Events


Event DateEvent Description
Friday, March 29, 2024CANCELLED SEC. 8 (6-YR)
Monday, September 19, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 19, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, August 16, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, July 17, 2017NOTICE OF ALLOWANCE CANCELLED
Monday, August 7, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 17, 2017TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, July 11, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 16, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 7, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 4, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 4, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 4, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 22, 2017ASSIGNED TO LIE
Monday, March 6, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, February 8, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 8, 2017LETTER OF SUSPENSION E-MAILED
Wednesday, February 8, 2017SUSPENSION LETTER WRITTEN
Wednesday, February 8, 2017ASSIGNED TO EXAMINER
Wednesday, November 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 14, 2016NEW APPLICATION ENTERED